Leonabio, Inc. · NASDAQ:LONA
Sermonix Pharmaceuticals, Inc. reported a 36.90% stake in Leonabio, Inc. (Schedule 13D)
Event Aug 24, 2026 · Filed Aug 31, 2026
Sermonix Pharmaceuticals, Inc. reported a 36.90% stake in Leonabio, Inc., 5,502,402 shares, with active intent on Aug 24, 2026. Filed Aug 31, 2026 (Schedule 13D).
- Stake
- 36.90%
- Shares
- 5,502,402
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sermonix Pharmaceuticals, Inc. | 36.90% | 5,502,402 |
| Portman David J. | 36.90% | 5,502,402 |
Source
Related
- Leonabio, Inc.
- Sermonix Pharmaceuticals, Inc.
- Leonabio, Inc. shareholders
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026